Jump to navigation
Australia’s most comprehensive source of medical news, opinion and analysis.
Why we want to help pave the way for new pain treatment
Few GPs believe the new program is helpful.
Hepatitis C is shaping up as an Australian success story, writes Jocelyn Wright.
No caffeine isn't in the top 10, even if it is the most enjoyed.
But there's five pathological causes to watch for, experts say.
The interleukin-17A inhibitor also benefited the joints.
The short treatment duration may benefit groups with poor adherence
Professor Gerald Holtmann on targeting the gastrointestinal biome as a whole.
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.